DAFNA Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.9M | Buy |
677,176
+21,000
| +3% | +$773K | 6.88% | 3 |
|
|
2025
Q1 | $23.2M | Buy |
656,176
+25,000
| +4% | +$884K | 6.58% | 3 |
|
|
2024
Q4 | $27.6M | Buy |
631,176
+113,182
| +22% | +$4.95M | 7.02% | 3 |
|
|
2024
Q3 | $23.5M | Buy |
517,994
+6,100
| +1% | +$277K | 5.55% | 3 |
|
|
2024
Q2 | $19.9M | Hold |
511,894
| – | – | 4.75% | 5 |
|
|
2024
Q1 | $16.5M | Hold |
511,894
| – | – | 3.76% | 6 |
|
|
2023
Q4 | $14.7M | Buy |
511,894
+38,500
| +8% | +$1.1M | 3.52% | 8 |
|
|
2023
Q3 | $13.1M | Sell |
473,394
-38,891
| -8% | -$1.08M | 4.08% | 5 |
|
|
2023
Q2 | $13.7M | Sell |
512,285
-63,500
| -11% | -$1.7M | 3.75% | 5 |
|
|
2023
Q1 | $12.5M | Buy |
575,785
+98,000
| +21% | +$2.12M | 3.74% | 7 |
|
|
2022
Q4 | $11.4M | Sell |
477,785
-2,000
| -0.4% | -$47.6K | 3.21% | 9 |
|
|
2022
Q3 | $9.46M | Buy |
479,785
+180,000
| +60% | +$3.55M | 2.54% | 10 |
|
|
2022
Q2 | $5.84M | Buy |
299,785
+67,684
| +29% | +$1.32M | 1.59% | 17 |
|
|
2022
Q1 | $5.92M | Buy |
232,101
+19,870
| +9% | +$507K | 1.54% | 19 |
|
|
2021
Q4 | $5.34M | Buy |
212,231
+2,500
| +1% | +$62.9K | 1.34% | 21 |
|
|
2021
Q3 | $5.77M | Hold |
209,731
| – | – | 1.53% | 19 |
|
|
2021
Q2 | $6.66M | Buy |
209,731
+58,500
| +39% | +$1.86M | 1.39% | 20 |
|
|
2021
Q1 | $6.94M | Buy |
151,231
+128,731
| +572% | +$5.91M | 1.65% | 15 |
|
|
2020
Q4 | $891K | Buy |
+22,500
| New | +$891K | 0.27% | 60 |
|